Press Releases
Novo Nordisk offers free 90-day insulin supply to people experiencing financial hardship due to COVID-19
People with diabetes using Novo Nordisk Inc. insulin who have lost health insurance coverage because of a change in job status due to the COVID-19 pandemic may now be eligible for enrollment in our Diabetes Patient Assistance Program (PAP)...
Press Releases
Labguru announces $1M pro-bono program for COVID-19 treatment developers
BioData is offering a pro-bono programme allowing free access to its flagship Labguru electronic laboratory notebook (ELN) to academic laboratories, non-profit organizations and small start-ups working on COVID-19 treatment or vaccine development, up to a total value of $1M.
The...
Press Releases
Virtual acceptance test for a Noack blister machine successful live stream of the FAT
Romaco is responding to the corona crisis by taking new approaches with the factory acceptance tests for its machines. The first Romaco Noack blister machine for a pharmaceutical producer in southern China has now passed its virtual FAT, which...
Press Releases
Orig3n Receives FDA Emergency Use Authorization For Coronavirus 2019 Test
Orig3n, Inc., a Boston-based company pioneering the future of wellness and health through genetics and biotechnology, is offering the Orig3n 2019 Novel Coronavirus (COVID-19) Test under an EUA from FDA, to authorized healthcare providers and institutions nationwide. The test...
Packaging & Labelling
KLM and Philips to set up a special freight airlift from Amsterdam to China
With the current loss of around 90% of all flights between Europe and Asia, there is a major shortage of freight capacity. At the same time, and precisely because of the crisis surrounding COVID-19, there is a huge requirement...
Press Releases
South Dakota launches clinical trial of hydroxychloroquine
South Dakota has launched a clinical trial to test the effectiveness of hydroxychloroquine in treating and potentially preventing COVID-19.
Gov. Kristi Noem (R) on Monday said South Dakota is the first state to conduct a full clinical trial on hydroxychloroquine....
Press Releases
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies
Samsung Biologics and Vir Biotechnology, Inc. announced a manufacturing agreement under which Samsung Biologics will perform large scale manufacturing services for Vir’s SARS-CoV-2 monoclonal antibody (mAb) program.
“We are proud to be working as a partner with Vir in their...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.